Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Celularity IncCELU · Entity 7145 | Director | January 12, 2026 | January 15, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Celularity Inc
Report date January 12, 2026 · Filed January 15, 2026 · Amendment
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Class A Common StockSEC Table I · non-derivative | Direct | 153,847 |
Reported balance
After 2026-01-12 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2026-01-12 · Grant · Acquired 28,847 · Balance 153,847 F1: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. F2: Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
F2: Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 12, 2026 Filed Jan 14, 2026 20:53 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 28,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-002300 · ownership.xml · nonDerivative · entry 1 LeVien Vincent · CIK 0002076464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,847 F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 · balance_after: Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
| January 12, 2026 Filed Jan 15, 2026 16:15 UTC Amendment | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 28,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-26-002423 · ownership.xml · nonDerivative · entry 1 LeVien Vincent · CIK 0002076464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 153,847 F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. F2 · balance_after: Includes 28,847 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest immediately upon grant. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 16:30 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Options · Derivative | 156,250 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-25-029618 · ownership.xml · derivative · entry 2 LeVien Vincent · CIK 0002076464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 156,250 Underlying: Class A Common Stock · 156,250 shares Expires 2035-12-29 F3 · derivative.exercise_date: This option was granted under the 2021 Plan and shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
| December 29, 2025 Filed Dec 30, 2025 16:30 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 125,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-029618 · ownership.xml · nonDerivative · entry 1 LeVien Vincent · CIK 0002076464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. F2 · balance_after: Includes 125,000 RSUs granted under the 2021 Plan, with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the earlier of the one-year anniversary of the date of grant and the next annual stockholder meeting, subject to the Reporting Person's continuous service with the Issuer through such date. Read SEC document |
| November 19, 2025 Filed Nov 21, 2025 16:17 UTC | Celularity Inc CELU · Entity 7145 | GrantClass A Common Stock | 3,699 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-024633 · ownership.xml · nonDerivative · entry 1 LeVien Vincent · CIK 0002076464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,699 F1 · shares: These shares represent restricted stock units ("RSUs") granted under the Celularity Inc. 2021 Equity Incentive Plan (the "2021 Plan"), with each RSU representing a right to receive one share of the Issuer's Class A common stock. The RSUs shall vest and become exercisable on the date of grant. Read SEC document |
| June 05, 2025 Filed Jul 28, 2025 16:30 UTC | Celularity Inc CELU · Entity 7145 | GrantStock Options · Derivative | 186,336 | $0.00 Strike: $1.92 | $0.00 |
DisclosureSEC source: 0001641172-25-021166 · ownership.xml · derivative · entry 1 LeVien Vincent · CIK 0002076464 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 186,336 Underlying: Class A Common Stock · 186,336 shares Expires 2035-06-05 F1 · derivative.exercise_date: 62,112 options vest over 3 years beginning on June 5, 2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.